A new approach for anthelmintic discovery for humans

Area of Science:

• Drug discovery and development
• Natural product chemistry
• Parasitic infections research

Background:

• Pharmaceutical industry has reduced focus on natural product drug discovery.
• Developing countries, especially in Africa, rely heavily on traditional medicines from local biodiversity.
• Africa faces persistent parasitic infections with limited regional drug discovery funding.

Purpose of the Study:

• To propose a sustainable model for local drug discovery in resource-constrained African settings.
• To introduce an innovative partnership leveraging local leadership and technology.
• To address the need for novel anthelmintic candidates from African natural products.

Main Methods:

• Utilizing a recombinant yeast-based assay for high-throughput screening.
• Screening collections of African natural products for anthelmintic activity.
• Fostering a partnership model that promotes local leadership and capacity building.

Main Results:

• The described partnership model facilitates the screening of African natural products.
• A recombinant yeast assay is effectively employed for identifying potential anthelmintic candidates.
• The strategy supports the development of sustainable local drug discovery programs.

Conclusions:

• Innovative partnerships are crucial for sustainable drug discovery in biodiversity-rich, resource-limited regions.
• Harnessing local leadership and advanced assays can unlock the potential of African natural products.
• This approach can build essential local capacity for discovering treatments for neglected diseases like parasitic infections.